Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection (CyPaM2)
Evaluation of an Innovative Medical Device Made of a Bimodal Endoscopic Imager and of a Software for Panoramic Images Building of the Bladder Inner Wall (French National Research Agency, CyPaM2 Project, ANR-11-TECS-001) (CyPaM2)
Sponsor: Institut de Cancérologie de Lorraine
This NA trial investigates Bladder Cancer and is currently completed. Institut de Cancérologie de Lorraine leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Sep 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Sep 2018 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2017 — May 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut de Cancérologie de Lorraine
For direct contact, visit the study record on ClinicalTrials.gov .